Welcome to our dedicated page for Petco Health & Wellness Company SEC filings (Ticker: WOOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) provides access to the company’s official regulatory disclosures, including annual, quarterly and current reports. Through filings such as Form 10-K and Form 10-Q, Petco reports detailed information on its net sales from products and from services and other revenue, gross profit, selling, general and administrative expenses, operating income or loss, interest expense, net income or loss and cash flows. These filings also present balance sheet data covering assets, liabilities and stockholders’ equity, along with information on lease obligations and senior secured credit facilities.
Petco frequently uses Form 8-K to furnish earnings press releases under Item 2.02 (Results of Operations and Financial Condition). These 8-K filings attach full-text earnings releases as exhibits and may also reference scheduled webcasts where management discusses quarterly or annual results. Other 8-K filings report matters such as participation in investor conferences and the results of stockholder votes at the annual meeting, including director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm.
For investors analyzing WOOF, the SEC filings are a primary source for understanding Petco’s financial performance, capital structure and governance. They detail the company’s use of non-GAAP measures such as Adjusted EBITDA and Free Cash Flow, along with reconciliations to the most comparable GAAP measures. Filings also include discussions of guidance assumptions, risk factors and forward-looking statements related to net sales, earnings outlooks, cost action plans and transformation efforts.
On Stock Titan, these filings are updated as they are made available through EDGAR, and AI-powered tools can help summarize lengthy documents, highlight key trends in revenue and profitability, and surface information on topics such as debt levels, lease commitments and stockholder voting outcomes. This allows users to review Petco’s historical and current disclosures efficiently while maintaining direct access to the underlying SEC documents.
Petco Health & Wellness Company (WOOF) – Form 4 filing, 28-Jul-2025
Director Iris Yen reported an acquisition (Code A) of 43,422 restricted stock units (RSUs) on 24-Jul-2025 under the company’s 2021 Equity Incentive Plan. Each RSU converts 1-for-1 into Class A common shares at no cost to the insider. The award vests on the earlier of the next annual shareholder meeting or 24-Jul-2026, encouraging one-year board-level alignment with shareholders.
Post-grant holdings:
- Direct: 145,787 Class A shares
- Indirect: 1,983 shares held via the Yen-Geniblazo Family Trust
Petco Health & Wellness Company, Inc. (WOOF) – Form 4
Chief Legal Officer & Secretary Giovanni Insana reported a Code F transaction on 21 Jul 2025. Code F denotes issuer share withholding to satisfy taxes due upon vesting of restricted stock units (RSUs); no open-market trade occurred. 1,083 Class A shares were withheld at an implied $3.30 per share.
Following the settlement, Insana’s beneficial ownership stands at 469,064 Class A shares, which includes 369,727 outstanding RSUs granted under the 2021 Equity Incentive Plan. Because the transaction is administrative and represents less than 0.3 % of his total holdings, it does not materially alter the executive’s economic exposure. The filing is therefore viewed as routine and low-impact for investors.
Petco Health & Wellness Company, Inc. (WOOF) – Form 4 insider filing, 24 Jun 2025
Director Iris Yen reported the acquisition of 20,576 Class A common shares on 20 Jun 2025 at an indicated value of $2.47 per share (transaction code “A” indicates a stock grant/award, not an open-market purchase). Following the transaction, Yen’s direct ownership rose to 102,365 shares; an additional 1,983 shares are held indirectly through the Yen-Geniblazo Family Trust. The filing notes that 49,254 of the directly held shares are restricted stock units (RSUs) issued under the company’s 2021 equity plan, each convertible into one share upon vesting.
The grant increases the director’s total reported beneficial stake by roughly 25% versus pre-grant levels (derived from disclosed balances). While insider acquisitions can signal confidence, the use of RSU awards means the transaction reflects routine board compensation rather than discretionary buying. No sales were reported, and there are no accompanying derivative transactions. Overall, the filing modestly deepens insider alignment but is unlikely to be materially impactful to the company’s capital structure or trading dynamics given Petco’s ~300 million outstanding shares.